Harald Engelhardt

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Journal of medicinal chemistry

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature cancer

Angewandte Chemie (International ed. in English)

This page only lists publications with an associated author ORCID identifier.

Publications

Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James C Tarr, James M Salovich, Martin Aichinger, KyuOk Jeon, Nagarathanam Veerasamy, John L Sensintaffar, Heribert Arnhof, Matthias Samwer, Plamen P Christov, Kwangho Kim, Tobias Wunberg, Norbert Schweifer, Francesca Trapani, Allison Arnold, Florian Martin, Bin Zhao, Nagaraju Miriyala, Danielle Sgubin, Stuart Fogarty, William J Moore, Gordon M Stott, Edward T Olejniczak, Harald Engelhardt, Dorothea Rudolph, Taekyu Lee, Darryl B McConnell, Stephen W Fesik
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors. Journal of medicinal chemistry 67 (16) (2024)
James C Tarr, James M Salovich, Martin Aichinger, KyuOk Jeon, Nagarathanam Veerasamy, John L Sensintaffar, Heribert Arnhof, Matthias Samwer, Plamen P Christov, Kwangho Kim, Tobias Wunberg, Norbert Schweifer, Francesca Trapani, Allison Arnold, Florian Martin, Bin Zhao, Nagaraju Miriyala, Danielle Sgubin, Stuart Fogarty, William J Moore, Gordon M Stott, Edward T Olejniczak, Harald Engelhardt, Dorothea Rudolph, Taekyu Lee, Darryl B McConnell, Stephen W Fesik
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors. Journal of medicinal chemistry (2024)
James C Tarr, James M Salovich, Martin Aichinger, KyuOk Jeon, Nagarathanam Veerasamy, John L Sensintaffar, Heribert Arnhof, Matthias Samwer, Plamen P Christov, Kwangho Kim, Tobias Wunberg, Norbert Schweifer, Francesca Trapani, Allison Arnold, Florian Martin, Bin Zhao, Nagaraju Miriyala, Danielle Sgubin, Stuart Fogarty, William J Moore, Gordon M Stott, Edward T Olejniczak, Harald Engelhardt, Dorothea Rudolph, Taekyu Lee, Darryl B McConnell, Stephen W Fesik
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors. Journal of medicinal chemistry 67 (16) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
James C Tarr, James M Salovich, Martin Aichinger, KyuOk Jeon, Nagarathanam Veerasamy, John L Sensintaffar, Heribert Arnhof, Matthias Samwer, Plamen P Christov, Kwangho Kim, Tobias Wunberg, Norbert Schweifer, Francesca Trapani, Allison Arnold, Florian Martin, Bin Zhao, Nagaraju Miriyala, Danielle Sgubin, Stuart Fogarty, William J Moore, Gordon M Stott, Edward T Olejniczak, Harald Engelhardt, Dorothea Rudolph, Taekyu Lee, Darryl B McConnell, Stephen W Fesik
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors. Journal of medicinal chemistry 67 (16) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Ulrike Tontsch-Grunt, Paula-Elena Traexler, Anke Baum, Hanny Musa, Kristell Marzin, Shaonan Wang, Francesca Trapani, Harald Engelhardt, Flavio Solca
Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic. British journal of cancer 127 (3) (2022)
Birgit Wilding, Dirk Scharn, Dietrich Böse, Anke Baum, Valeria Santoro, Paolo Chetta, Renate Schnitzer, Dana A Botesteanu, Christoph Reiser, Stefan Kornigg, Petr Knesl, Alexandra Hörmann, Anna Köferle, Maja Corcokovic, Simone Lieb, Guido Scholz, Jens Bruchhaus, Markus Spina, Josef Balla, Biljana Peric-Simov, Jasmin Zimmer, Sophie Mitzner, Thomas N Fett, Alexandra Beran, Lyne Lamarre, Thomas Gerstberger, Daniel Gerlach, Markus Bauer, Andreas Bergner, Andreas Schlattl, Gerd Bader, Matthias Treu, Harald Engelhardt, Stephan Zahn, Julian E Fuchs, Johannes Zuber, Peter Ettmayer, Mark Pearson, Mark Petronczki, Norbert Kraut, Darryl B McConnell, Flavio Solca, Ralph A Neumuller
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling. Nature cancer 3 (7) (2022)
Gerald Platzer, Moriz Mayer, Andreas Beier, Sven Brüschweiler, Julian E Fuchs, Harald Engelhardt, Leonhard Geist, Gerd Bader, Julia Schörghuber, Roman J Lichtenecker, Bernhard Wolkerstorfer, Dirk Kessler, Darryl B McConnell, Robert Konrat
PI by NMR: Probing CH-π Interactions in Protein-Ligand Complexes by NMR Spectroscopy. Angewandte Chemie (International ed. in English) 59 (35) (2020)
Harald Engelhardt, Dietrich Böse, Mark Petronczki, Dirk Scharn, Gerd Bader, Anke Baum, Andreas Bergner, Eugene Chong, Sandra Döbel, Georg Egger, Christian Engelhardt, Peter Ettmayer, Julian E Fuchs, Thomas Gerstberger, Nina C Gonnella, Andreas Grimm, Elisabeth Grondal, Nizar Haddad, Barbara Hopfgartner, Roland Kousek, Mariusz Krawiec, Monika Kriz, Lyne Lamarre, Joyce Leung, Moriz Mayer, Nitinchandra D Patel, Biljana Peric Simov, Jonathan T Reeves, Renate Schnitzer, Andreas Schrenk, Bernadette Sharps, Flavio Solca, Heinz Stadtmüller, Zhulin Tan, Tobias Wunberg, Andreas Zoephel, Darryl B McConnell
Start Selective and Rigidify: The Discovery Path toward a Next Generation of EGFR Tyrosine Kinase Inhibitors. Journal of medicinal chemistry 62 (22) (2019)

Harald Engelhardt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Harald Engelhardt